Skip to main content
SpringerLink
Log in

A Novel Potential Therapy for Spinal Muscular Atrophy

  • Clinical Trials Report
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ciafaloni E, Sanders DB: Advances in myasthenia gravis. Curr Neurol Neurosci Rep 2002, 2:89–95.

    Article  PubMed  Google Scholar 

  2. Palace J, Newsom-Davis J, Lecky B: A randomized doubleblind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group. Neurology 1998, 50:1778–1783.

    PubMed  CAS  Google Scholar 

  3. Gronseth GS, Barohn RJ: Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000, 55:7–15.

    PubMed  CAS  Google Scholar 

  4. Jaretzki A 3rd, Barohn RJ, Ernstoff RM, et al.: Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 2000, 55:16–23.

    PubMed  Google Scholar 

  5. Melki J, Lefebvre S, Burglen L, et al.: De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. Science 1994, 264:1474–1477.

    Article  PubMed  CAS  Google Scholar 

  6. Kissel JT, McDermott MP, Mendell JR, et al.: Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology 2001, 57:1434–1440.

    PubMed  CAS  Google Scholar 

  7. Martineau L, Horan MA, Rothwell NJ, Little RA: Salbutamol, a beta 2-adrenoceptor agonist, increases skeletal muscle strength in young men. Clin Sci (Lond) 1992, 83:615–621.

    CAS  Google Scholar 

Download references

Authors
  1. Michio Hirano MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hirano, M. A Novel Potential Therapy for Spinal Muscular Atrophy. Curr Neurol Neurosci Rep 3, 56 (2003). https://doi.org/10.1007/s11910-003-0038-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-003-0038-5

Keywords

Search

Navigation